維持性血液透析合并難治性繼發(fā)性甲狀旁腺功能亢進(jìn)患者腹主動脈鈣化相關(guān)因素分析
[Abstract]:Objective: to investigate the risk factors of abdominal aortic calcification (AAC) in patients with maintenance hemodialysis (MHD) combined with refractory secondary hyperparathyroidism (r SHPT). Methods: from May 2014 to January 2016, r SHPT patients undergoing parathyroidectomy in China-Japan Friendship Hospital were selected. The general status of the patients was recorded, and the serum total parathyroid hormone (i PTH), serum calcium (Ca), was recorded. Serum phosphorus (P) and bone transformation markers were measured. Bone mineral density (BMD),) was measured and divided into three groups according to AAC score: no calcification, mild calcification and moderate and severe calcification. The difference between the three groups was compared. Results: 82 patients with r SHPT were enrolled in the study. The age was 50.99 鹵12.98 years old and the dialysis age was 88.42 鹵50.15 months. The incidence of 48.8%.AAC was 63.4% in 40 male patients. Of them, 20 cases (24.4%) were involved in the four segments of L1~L4. Male AAC score was higher (P0. 016). Compared with the non-calcification group, the two groups with calcification were older (P0.001) and longer dialysis age (P0.05); the type I collagen carboxyl terminal peptide (CTX) of mild and moderate calcification group was significantly lower than that of non-calcified group (P0.05). Multiple linear regression analysis showed that AAC was positively correlated with age (r = 0.042), serum phosphorus (r = 0.438), and negatively correlated with CTX (r = 0.100). Conclusion: the incidence of AAC in patients with MHD and r SHPT is high. The elderly, male, high blood phosphorus and low CTX are the risk factors of vascular calcification.
【作者單位】: 山西醫(yī)科大學(xué);中日友好醫(yī)院腎內(nèi)科;中日友好醫(yī)院放射科;山西省人民醫(yī)院腎內(nèi)科;
【基金】:首都臨床特色應(yīng)用研究與成果推廣(Z151100004015112)
【分類號】:R581.1;R692
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 良介;;高骨鈣蛋白濃度降低腹主動脈鈣化進(jìn)展[J];實(shí)用糖尿病雜志;2013年02期
2 申衛(wèi)平,林春靜,韓盈,丁遼平;高尿酸血癥與腹主動脈粥樣硬化(96例臨床配對分析)[J];中華內(nèi)分泌代謝雜志;1991年03期
3 周觀彥;方海燕;余霞;;維持性血液透析應(yīng)用肝素致脫發(fā)1例[J];中國血液凈化;2009年06期
4 苗華;洪虹;潘明明;朱竹先;呂敏;;維持性血液透析患者繼發(fā)性甲狀旁腺功能亢進(jìn)的治療觀察[J];中國血液凈化;2007年01期
5 許志忠;陳永忠;朱再志;李俊;;維持性血液透析患者頭孢菌素腦病13例臨床分析[J];四川醫(yī)學(xué);2008年11期
6 黃恬;余毅;;維持性血液透析患者繼發(fā)性甲狀旁腺功能亢進(jìn)及其治療[J];世界臨床藥物;2010年11期
7 徐麗娟;盧曉昭;鄒曉榮;李照輝;羅會文;于桂琴;吳雅嵐;張曉鳳;;維持性血液透析患者甲狀腺功能減退癥與貧血的臨床相關(guān)性分析[J];中國血液凈化;2013年04期
8 王素霞;孟建中;景穎;呂蘇一;高飛;;維持性血液透析發(fā)生高滲性非酮癥糖尿病昏迷1例[J];實(shí)用醫(yī)藥雜志;2010年03期
9 王艷璇;姜洋;;維持性血液透析并發(fā)高鉀血癥38例診治分析[J];中國誤診學(xué)雜志;2008年24期
10 陳永華;龐慧華;朱銘力;陸任華;周文彥;顧樂怡;張偉明;錢家麒;嚴(yán)玉澄;;維持性血液透析患者中代謝綜合征發(fā)病情況及危險(xiǎn)因素分析[J];上海交通大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年05期
相關(guān)會議論文 前2條
1 金領(lǐng)微;李占圓;陳輝樂;戴彩香;;維持性血液透析患者骨質(zhì)梳松的患病率[A];2007年浙滬兩地腎臟病學(xué)術(shù)年會資料匯編[C];2007年
2 金領(lǐng)微;李占圓;陳輝樂;戴彩香;;維持性血液透析患者骨質(zhì)疏松患病率的臨床分析[A];中華醫(yī)學(xué)會第11屆全國內(nèi)科學(xué)術(shù)會議論文匯編[C];2007年
相關(guān)碩士學(xué)位論文 前1條
1 張斌;維持性血液透析患者甲狀旁腺功能低下影響因素分析[D];山東大學(xué);2015年
,本文編號:2404126
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/2404126.html